Lundbeck, Otsuka to co-develop AD vaccine

H. Lundbeck A/S and Otsuka Pharmaceutical Co Ltd have decided to advance an anti-amyloid beta vaccine, currently in preclinical development, for the treatment of Alzheimer’s disease. The focus is on early inhibition of amyloid beta.